Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, Jotham W., Brooks, Paige R., Vetelino, Michael G., Wirtz, Michael C., Arnold, Eric P., Huang, Jianhua, Sands, Steven B., Davis, Thomas I. +13 more·2005·Journal of Medicinal Chemistry

DOI 10.1021/jm050069n

Cited by (960)

Items 701–800 of 960

Smoking and Schizophrenia: Prevalence, Mechanisms and Implications for Treatment
Corinne Cather, Ruth S. Barr, Anne Eden Evins · 2008 · Clinical Schizophrenia & Related Psychoses
Dépendance aux drogues : avancées de la neurobiologie et perspectives thérapeutiques
Nicolas Marie, Florence Noble · 2012 · La Presse Médicale
Le sevrage tabagique
G. Peiffer, Michel Underner, J. Perriot, Nadine Paillot, F. Renolleau · 2013 · Revue des Maladies Respiratoires Actualités
How Do We Safely Get People to Stop Smoking?
David Chi-Leung Lam, John Dorrance Minna · 2011 · Cancer Prevention Research
Role of CHRNA5-A3 Genetic Locus Variants and Developing Drug for Chronic Obstructive Pulmonary Disease
Filippo Lococo, Alfredo Cesario, Leonardo Petracca Ciavarella, Pierluigi Maria Granone, Patrizia Russo · 2012 · Current Medicinal Chemistry
Nicotine Dependence and Depression, What is the Future for Therapeutics?
Roger L. Papke, Marina R. Picciotto · 2012 · Journal of Addiction Research & Therapy
Varenicline
Cheryl A. Oncken, David H. Gonzales, Mitchell A. Nides, Steven I. Rennard, Eric J. Watsky, Jotham W. Coe · 2006 · CRC Press eBooks
Affordable Care Act: Patient-Centered Medical Homes and Implications for Mental Health
Vanita Sahasranaman · 2016 · American Journal of Psychiatry Residents Journal
Acute Worsening of Tics on Varenicline
Shivam Om Mittal, Bryan T. Klassen, Anhar Hassan, James H. Bower, Elizabeth A. Coon · 2017 · Clinical Neuropharmacology
Presynaptic Nicotinic Acetylcholine Receptors and the Modulation of Circuit Excitability
Chongbo Zhong, Gretchen Y. López‐Hernández, David A. Talmage, Lorna W. Role · 2014 · The Receptors
Smoking cessation through the utilization of pharmacotherapy
Kathy Harrington, William C. Bailey · 2009 · Expert Review of Respiratory Medicine
The neurobiological basis for partial agonist treatment of nicotine dependence
Paul N Aveyard · 2006 · International Journal of Clinical Practice
integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
Kacper Więcław, Katarzyna Stańko, Laura Piasek, Adrianna Szafran, Klaudia Wiśniewska, Agnieszka Ostańska, Wiktor Terelak, Marcin Ciechański, Edyta Witkowska, Grzegorz Godek · 2023 · Journal of Education Health and Sport
Smoking cessation in India: A narrative review
Anubhuti Singh, Kislay Kishore · 2025 · Lung India
Understanding varenicline function via key receptor and ligand interactions
Sheenagh Aiken, Daniele Fiorito, Matthew Harper, Grzegorz Pikus, Juno Underhill, Jacob Murray, Joshua Rawlinson, AnnMarie C. O’Donoghue, Cecilia Gotti, Sarah C. R. Lummis et al. · 2025 · Cell Reports Physical Science
A virtual reality craving study in tobacco addiction: The role of non-pharmacological support in tobacco detox therapy
Lorenzo Zamboni, Simone Campagnari, Rosaria Giordano, Francesca Fusina, Silvia Carli, Alessio Congiu, Isabella Barbon, Silvia Melchiori, Rebecca Casari, Elisa Tedeschi et al. · 2022 · Frontiers in Psychiatry
Changes in distinct brain systems identified with fMRI during smoking cessation treatment with varenicline: a review
Vassilis N. Panagopoulos, Alexis Bailey, George Kostopoulos, Andreas A. Ioannides · 2024 · Psychopharmacology
Parkinsonism Related to Varenicline in a Patient During Smoking Cessation
Ali Ulvi Uca, Hasan Hüseyin Kozak, Faruk Uğuz, Haluk Gümüş · 2015 · Journal of Clinical Psychopharmacology
Individual variations in motives for nicotine self-administration in male rats: evidence in support for a precision psychopharmacology
Vernon Garcia‐Rivas, Jean-François Fiancette, Jessica Tostain, Giulia de Maio, Matias Ceau, Jean‐François Wiart, Jean‐Michel Gaulier, Véronique Deroche‐Gamonet · 2024 · Translational Psychiatry
SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats
Kevin M. Braunscheidel, George Voren, Christie D. Fowler, Qun Lu, Alexander Kuryatov, Michael D. Cameron, Inés Ibáñez-Tallon, Jon Martin Lindstrom, Theodore M. Kamenecka, Paul J. Kenny · 2024 · Frontiers in Molecular Neuroscience
Affinity purification of a chimeric nicotinic acetylcholine receptor in the agonist and antagonist bound states
Shenping Liu, Merrill S. Babcock, Jacob Bode, Jeanne S. Chang, Heinz Fischer, Robert L. Garlick, Gurnam S. Gill, Eric T. Lund, Brandon J. Margolis, W. Rodney Mathews et al. · 2011 · Protein Expression and Purification
Varenicline does not alter brain stimulation reward thresholds and reverses nicotine‐facilitated thresholds in rats
Robert E. Vann, K.M. Tobey, Samuel Lobe, Barbara R. Kipps, Andrew J. Kwilasz, Mario D. G. Aceto, Louis S. Harris · 2010 · Drug Development Research
Fiscal Impact of Smoking Cessation in Thailand: A Government Perspective Cost-Benefit Analysis
Mark P. Connolly, Nikolaos Kotsopoulos, Pichaya Suthipinijtham, Suthat Rungruanghiranya · 2018 · Asia Pacific Journal of Public Health
Varenicline rescues nicotine-induced decrease in motivation for sucrose reinforcement
Erin E. Hart, Daniel Hertia, Scott T. Barrett, Sergios Charntikov · 2020 · Behavioural Brain Research
Detecting and classifying neurotransmitter signals from ultra-high sensitivity PET data: the future of molecular brain imaging
Heather Liu, Evan D. Morris · 2021 · Physics in Medicine and Biology
Cytisine induced urticaria : a case report during a smoking cessation treatment.
Simone Campagnari, Rebecca Casari, Lorenzo Zamboni, Francesca Fusina, Fabio Lugoboni · 2022 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
Desensitizing nicotinic agents normalize tinnitus-related inhibitory dysfunction in the auditory cortex and ameliorate behavioral evidence of tinnitus
Madan Ghimire, Rui Cai, Lynne L. Ling, Kevin A. Brownell, Kurt W. Wisner, Brandon C. Cox, Troy A. Hackett, Thomas J. Brozoski, Donald M. Caspary · 2023 · Frontiers in Neuroscience
Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders
João Maurício Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel Kanaan Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio César Torales, Antonio Ventriglio et al. · 2023 · International Review of Psychiatry
Pharmakologische Strategien zur Unterstützung einer Raucherentwöhnung
Nenad Vasić, Robert Christian Wolf, Nadine Donata Wolf, Bernhard J. Connemann, Zrinka Sosic-Vasic · 2011 · Der Nervenarzt
Medication Development for the Treatment of Substance Abuse
Brian S. Fulton · 2008 · Annual reports in medicinal chemistry
Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen
Adebowale E. Ogunjirin, Joseph Fortunak, LaVerne L. Brown, Yingxian Xiao, Martha I. Dávila‐García · 2015 · Neurochemical Research
PREDICTORS OF QUIT SUCCESS IN BELGIAN PARTICIPANTS OF A VARENICLINE OBSERVATIONAL SMOKING CESSATION STUDY
Hedwig Boudrez, J-P Hoengenaert, Kris L. Nackaerts, Michael Messig, M Metcalfe · 2013 · Acta Clinica Belgica
Electrosensing Platform for Varenicline Based on Reduced Graphene Oxide
Nagappa Laxman Teradal, Prashanth S. Narayan, J. Seetharamappa, Ashis Kumar Satpati · 2014 · Electroanalysis
Smoking Cessation: Significance and Implications for Children
Andrea T. Borchers, Carl L. Keen, Merrill Eric Gershwin · 2007 · Clinical Reviews in Allergy & Immunology
Resting-State Functional Magnetic Resonance Imaging Reveals Overactivation of the Habitual Control Brain System in Tobacco Dependence
Qiaowen Tan, Shaoke Li, Juan Niu, Shien Liu, Yaling Li, Yujie Lu, Zhihong Wang, Wanqun Xu, Yalin Wei, Zongjun Guo · 2021 · Neuropsychiatric Disease and Treatment
Varenicline: A New Pharmaceutical Approach to Smoking Cessation
Patricia L. Dougherty · 2008 · Nursing for Women s Health
Novel Putative Positive Modulators of α4β2 nAChRs Potentiate Nicotine Reward-Related Behavior
Skylar Y. Cooper, Austin T. Akers, V. Blair Journigan, Brandon J. Henderson · 2021 · Molecules
Designing Safer Organocatalysts – What Lessons Can Be Learned When the Rebirth of an Old Research Area Coincides with the Advent of Green Chemistry?
Ian Beadham, Monika Gurbisz, Nicholas Gathergood · 2012 · Wiley eBooks
Varenicline: A review of the literature and place in therapy
Heather P. Whitley, Krystal L. Moorman · 2007 · Pharmacy Practice
Development of Nicotine Loaded Chitosan Nanoparticles for Lung Delivery
Hui Wang · 2017 · Queensland University of Technology
Benzoazabicyclo[4.3.1] derivatives by intramolecular Michael addition of piperidinone enolates to enoates
Gedu Satyanarayana, Sven Müller, Martin Edmund Maier · 2008 · Tetrahedron Letters
An example of cytisine overdose with no consequent side-effects: a case report
Simone Campagnari, Lorenzo Zamboni, Isabella Barbon, Francesca Fusina, Fabio Lugoboni · 2024 · Journal of Medical Case Reports
Pharmacotherapy of Tobacco Use Disorder
Shirshendu Sinha, Ajay Shah · 2016 · American Journal of Psychiatry Residents Journal
Neurobiology and Mechanisms of Nicotine Addiction
Hyma P. Gogineni, David P.L. Sachs, Darlene H. Brunzell · 2023 · Respiratory medicine
First Episode of Psychosis in the Context of Varenicline Treatment for Smoking Cessation
Yuri Zoghbi, Raja Barazi, Menatalla Abdelkader, Yassin Hassan Eltorki, Suhaila Ghuloum · 2023 · Cureus
Neuronal Nicotinic Acetylcholine Receptors in Reward and Addiction
Linzy M. Hendrickson, Andrew R. Tapper · 2014 · The Receptors
Eficacia y seguridad de vareniclina en el abandono del tabaquismo
S. Solano Reina, P. Vaquero Lozano, Raquel Solano García-Tenorio, J.C. Márquez Nieto, José Ignacio de Granda Orive, Carlos Andrés Jiménez Ruiz · 2012 · Revista de Fomento Social
First episode mania following cessation of varenicline (Champix)
Richard Baker, Nav Gill, Gordon Barraclough Parker · 2016 · Australasian Psychiatry
Chromosome 15q13.3 microduplications are associated with treatment refractory major depressive disorder
Lora Lee McClain, Anna Maria Segreti, Sharon Nau, Patricia Shaw, David N. Finegold, Lisa A. Pan, David Gerard Peters · 2019 · Genes Brain & Behavior
Combinaisons des traitements pharmacologiques au cours du sevrage tabagique. Revue systématique
M. Underner, J. Perriot, G. Peiffer, Anne-Marie Ruppert, I. de Chazeron, Nématollah Jaafari · 2021 · Revue des Maladies Respiratoires
UFR2709, an Antagonist of Nicotinic Acetylcholine Receptors, Delays the Acquisition and Reduces Long-Term Ethanol Intake in Alcohol-Preferring UChB Bibulous Rats
Gabriel Gálvez, Juan Pablo González-Gutiérrez, Martín Hödar-Salazar, Ramón Sotomayor‐Zárate, Marı́a Elena Quintanilla, María Elena Quilaqueo, Mario Rivera‐Meza, Patricio Iturriaga‐Vásquez · 2022 · Biomedicines
Condensation reactions of dialkoxy-2-phenylchroman-4-ones with 1,2-diamines: A method for the preparation of chromenoquinoxalines
Hannah Watkins, Gerald Lee, Pangbewindin H.B. Ouedraogo, Clifford W. Padgett, Khoa D. Nguyen, Rylan Artis, Brandon P. Quillian · 2023 · Tetrahedron Letters
How to facilitate smoking cessation
Furio Colivicchi, Stefania Angela Di Fusco, Vered Gil Ad, Silvia Castelletti, Luigi Pollarolo, Maria Laura Canale, Simona Giubilato, Roberta Rossini, Stefano Oliva, Andrea Tedeschi et al. · 2025 · Progress in Cardiovascular Diseases
Varenicline-induced manic episode
Ömer Geçici, Melike Nebioğlu, Mükerrem Güven · 2012 · Journal of Mood Disorders
Varenicline and evaluated outcomes in smoking cessation programmes
Pierachille Santus, Linda Bassi, Andrea Airoldi, F. Giovannelli, Dejan Radovanovic · 2015 · Monaldi Archives for Chest Disease
Alcohol and nicotinic acetylcholine receptors
Jinsong Tang, Yanhui Liao · 2013 · QScience Connect
Nicotine Replacement Therapies and Other Nicotinic Strategies
Jed E. Rose · 2006 · CRC Press eBooks
Psychotic Symptoms Associated With Varenicline in a Patient With Alcohol and Nicotine Dependence
Fumihiko Ueno, Hiroyuki Uchida, Takefumi Suzuki, Akira Yokoyama, Sachio Matsushita, Masaru Mimura, Susumu Higuchi · 2017 · Journal of Clinical Psychopharmacology
Evaluation of reproductive and renal toxicity of varenicline in male rats.
Fatih Oğuz, Ali Beytur, Elif Taşlıdere, Hakan Parlakpınar, Hilal Kurnaz Oğuz, Alaadin Polat, İbrahim Topçu, Nigar Vardı, Engin Burak Selçuk · 2019 · Europe PMC (PubMed Central)
Interactions between 2′-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors
Renata V. Bueno, Samuel Davis, Alice Dawson, Pauline W. Ondachi, Frank Ivy Carroll, William N. Hunter · 2022 · Acta Crystallographica Section D Structural Biology
Functional Distribution and Regulation of Neuronal Nicotinic ACh Receptors in the Mammalian Brain
Jerrel L. Yakel · 2014 · The Receptors
Synthesis of (1‐(Aminomethyl)‐2,3‐dihydro‐1H‐inden‐3‐yl)methanol: Structural Confirmation of the Main Band Impurity Found in Varenicline®Starting Material
Frank R. Busch, Paul E. Concannon, Robert E. Handfield, Jason D. McKinley, Megan E. McMahon, Robert A. Singer, Timothy J. N. Watson, Gregory J. Withbroe, Mariano Stivanello, Lucia Leoni et al. · 2008 · Synthetic Communications
Diagnosis of abuse and addiction
Otto Lesch, Henriette Walter, Christian Wetschka, Michie N. Hesselbrock, VICTOR M. HESSELBROCK · 2011 · Springer eBooks
Die medikamentöse Therapie von Missbrauch und Abhängigkeiten (Tabak, Alkohol und illegale Drogen)
Otto‐Michael Lesch, Werner E. Platz, Michael Soyka, Henriette Walter · 2010 · Springer eBooks
Nicotine Dependence: Current Treatments and Future Directions
Caryn E. Lerman, Robert A. Schnoll, Freda Patterson · 2008 · Elsevier eBooks
The thermodynamic profile and molecular interactions of a C(9)-cytisine derivative-binding acetylcholine-binding protein from Aplysia californica
Samuel Davis, Hugo Rego Campello, Timothy C. Gallagher, William N. Hunter · 2020 · Acta Crystallographica Section F Structural Biology Communications
Sonochemical protocol for solvent-free organic synthesis
Muhammad Faisal · 2020 · Elsevier eBooks
Synthesis of a Nitroxide Spin-labeled Varenicline (Chantix) Derivative
Balázs Bognár, Mostafa Isbera, Tamás Kálai · 2021 · Organic Preparations and Procedures International
Therapeutic concentrations of varenicline increases exocytotic release of catecholamines from human and rat adrenal chromaffin cells in the presence of nicotine
Amanda Jiménez‐Pompa, Sara Sanz‐Lázaro, Arik J. Hone, Lola Rueda‐Ruzafa, José Medina‐Polo, Carmen González Enguita, Jesús Blázquez, Cristóbal de los Rı́os, J. Michael McIntosh, Almudena Albillos · 2021 · Neuropharmacology
Understanding the stimulus effects of nicotine and bupropion in a drug-drug discriminated goal-tracking task
Andrea E. Moran, Y. Wendy Huynh, Andrew Finkner, Carly Selleck, Aelyn Thompson, Scott T. Barrett, Rick A. Bevins · 2022 · Psychopharmacology
Effects of nicotine and lipopolysaccharide stimulation on adhesion molecules in human gingival endothelial cells
Yukari Sato, Kosuke Maruyama, Masato Mikami, Soh Sato · 2022 · Odontology
Alcohol Use and Anxiety
Penelope P. Ziegler · 2007 · American Journal of Psychiatry
Adulthood Outcomes in Rats Following Repeated Adolescent Exposure to 1-Benzylpiperazine (BZP) and/or Ethanol.
Perry, James Colin · 2008 · UC Research Repository (University of Canterbury)
Smoking Prevention and Cessation
Alexander V. Prokhorov, Karen Suchanek Hudmon · 2014 · Lung Cancer
Varenicline (Chantix): An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Jotham W. Coe, Frank R. Busch, Robert A. Singer · 2010 · Wiley eBooks
Varenicline (Chantix) for Tobacco Dependence
2007 · Obstetrics and Gynecology
Tobacco Use Disorder and Treatment
Lisa M. Fucito, Stephen R. Baldassarri · 2018 · Elsevier eBooks
Good Practice Statements for the treatment of nicotine dependence
Renata Solimini, Otto Ruokolainen, Zsuzsa Cselkó, Helena Koprivnikar, Lorenzo Spizzichino, Stathis Papachristou, Adrián González‐Marrón, Emilia Nunes, Dolors Carnicer-Pont, Esteve Fernández et al. · 2023 · Tobacco Prevention & Cessation
Exploring the Link between Altitude of Residence and Smoking Patterns in the United States
Danielle Boxer, Young‐Hoon Sung, Nicolás A. Núñez, Colleen Elizabeth Fitzgerald, Perry Franklin Renshaw, Douglas G. Kondo · 2024 · International Journal of Environmental Research and Public Health
The Effect of Varenicline on Smoking Cessation in Hospitalized Patients: A Systematic Review and Meta-Analysis
Mahshid Aryanpur, Raheb Ghorbani, Sajjad Rashno, Gholamreza Heydari, Mehdi Kazempour Dizaji, Zahra Hessami, Narges Ghorbani · 2024 · Addiction and Health
The actions of varenicline on alkaloids from Conium maculatum (poison hemlock), Lupinus sulphureus (sulphur lupine) and Nicotiana glauca (tree tobacco)
Benedict T. Green, Stephen Tomas Lee, Kevin D. Welch, Daniel Cook, Clinton A. Stonecipher · 2024 · Toxicon
Effects of varenicline as an adjunct to analgesic and anti-inflammatory therapy in acute nerve injury
Volga Öztürk, Yasemen Adalı, Özge ERTENER, Yasemin Seval, Ali Engin Daştan, Serhat Ozgenc, Elif Barış · 2025 · Injury
Biphasic effect of nicotine on glutamatergic activity in male mouse brain
Prajakta Pramod Biyani, Ajay Sarawagi, Anant Bahadur Patel · 2025 · British Journal of Pharmacology
Noninvasive transcranial brain stimulation to treat addiction
Colleen Ann Hanlon, Ghazaleh Soleimani, Shirley Fecteau, Sara Honari, Tonisha Kearney-Ramos, Daniel M. McCalley, Claudia B. Padula, Afra Souki, Vaughn R. Steele, Hamed Ekhtiari · 2025 · Handbook of behavioral neuroscience
Synergistic effects of levo-tetrahydropalmatine and low-dose naltrexone on nicotine conditioned place preference in mice: a dual-target strategy based on dopamine and opioid systems
Kun Feng, Yiran Vicky Zhao, Li Liu, Shan Kang, Mingming Yu, Sherwin K. B. Sy, Zhihua Lv, Meixing Yan · 2026 · Frontiers in Pharmacology
Rare coding variants in CHRNB3 associate with reduced daily cigarette smoking across ancestries
Veera Manikandan Rajagopal, Andrey Ziyatdinov, Tyler Joseph, Ariane H. Ayer, Mohsin Ahmed, Joelle S. Mbatchou, Yuxin Zou, Amelia Averitt, Nilanjana Banerjee, Michael Cantor et al. · 2026 · Nature Communications
Nicotinic Acetylcholine Receptor Signaling Activates Beige Adipocytes and Mediates Systemic Metabolism
Shanshan Liu, Kezhou Zhu, Wenwen Zhang, Tong Pan, Martin O'Brien, Ichitaro Abe, Lily Dale, Justin Piejak, Nadia Houssein, Biyang Zhang et al. · 2026 · Diabetes
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial
Massimiliano Cani, Daniela Bafunno, Francesca Caumo, Silvia Novello, Salvatore Cardellicchio, Vincenzo Cilenti, Elena Davoli, Edoardo Mercadante, Ciro Battiloro, Aldo Cammarota et al. · 2026 · Journal of Thoracic Oncology
Substituted heteroaromatic compounds: effect on nicotine self-administration in rats
John Richard Cashman, Karl J. Okolotowicz, Matt A. Cerny, Robert Johnson, Aaron J. Janowsky, Marc R. Azar · 2012 · Psychopharmacology
Advances in Smoking Cessation
Carlos Andrés Jimenez-Ruiz, Karl Olov Fagerström · 2010 · Clinical Pulmonary Medicine
Extinction Burst after Varenicline Titration: A Case Report
Marc L. Steinberg, Jill M. Williams · 2013 · The Journal of Smoking Cessation
1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol
Jian Feng Xu, Hao Xu, Ji-Cai Quan, Fei Sha, Cheng Yao · 2008 · Acta Crystallographica Section E Structure Reports Online
Examination of Methamphetamine Reinstatement in Female and Male Rats: A Pre-Clinical Model of Relapse
Steven T. Pittenger · 2016 · Lincoln (University of Nebraska)
Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues
Pauline W. Ondachi, Ana H. Castro, Benjamin Sherman, Charles W. Luetje, Mohamad Imad Damaj, S. Wayne Mascarella, Hernán A. Navarro, Frank Ivy Carroll · 2016 · ACS Chemical Neuroscience
A Systematic Review Investigating the Impact of Modified Varenicline Regimens on Smoking Cessation
Aaron D. Drovandi, Peta-Ann Teague, Beverley Dawn Glass, Bunmi S. Malau‐Aduli · 2017 · The Journal of Smoking Cessation
The α7, α4β2 and α3β4 Nicotinic Acetylcholine Receptors: Characteristics, Role in Pathogenic Processes and Bioactive Compounds
Victor S. Batista, Nailton M. Nascimento-Júnior · 2016 · Revista Virtual de Química
Evaluation of pharmacological and non–pharmacological methods of smoking cessation; A Review
Nandita Gautam, KK Shivalingesh, Swati Sharma, Resham Irshad, Verma Satyaki · 2020 · Journal of Addiction Medicine and Therapeutic Science
New and emerging treatments in smoking cessation
Cindy Mui, Scott E. Sherman · 2008 · Journal of clinical outcomes management
Improved and ‘Nitrosamines Free’ Process for the Preparation of an α4β2 Neuronal Nicotinic Acetylcholine Receptor Agonist-Varenicline Tartrate
Ramesh Goura, Naresh Kumar Katari, A. K. Ramprasad, Pradeep Rebelli, Surendra Babu Manabolu Surya · 2022 · Polycyclic aromatic compounds
Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading
Samantha Johnstone, Robert K Cooper, Jennifer M. Wray, Sarah Tonkin, Kyler S. Knapp, Craig R. Colder, Eugene Maguin, Martin Christopher Mahoney, Stephen T. Tiffany, Thomas Henry Brandon et al. · 2025 · Nicotine & Tobacco Research